XML 25 R6.htm IDEA: XBRL DOCUMENT v3.23.1
Unaudited Interim Consolidated Statement Equity - USD ($)
$ in Millions
Total
Common Stock
Treasury Stock
Additional Paid-In Capital
Retained Earnings
Accumulated Other Comprehensive Income (Loss), Net
Noncontrolling Interests
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Celanese Corporation stockholders' equity   $ 0 $ (5,492) $ 333 $ 9,677 $ (329)  
Balance as of the beginning of the period (in shares) at Dec. 31, 2021   108,023,735 61,736,289        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock-based compensation, net of tax       (7)      
Purchases of treasury stock (in shares) 0   0        
Purchases of treasury stock, including related fees     $ 0        
Stock awards (in shares)   283,606          
Stock awards   $ 0          
Net earnings (loss) attributable to Celanese Corporation $ 502       502    
Common stock dividends         (73)    
Other comprehensive income (loss), net of tax (4)         (4)  
Balance as of the beginning of the period, noncontrolling interest at Dec. 31, 2021             $ 348
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net earnings (loss) attributable to noncontrolling interests 2           2
Dividends to noncontrolling interests             0
Distributions to noncontrolling interests             (4)
Balance as of the end of the period, noncontrolling interest at Mar. 31, 2022             346
Balance as of the end of the period (in shares) at Mar. 31, 2022   108,307,341 61,736,289        
Balance as of the end of the period at Mar. 31, 2022 4,953            
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Celanese Corporation stockholders' equity 4,607 $ 0 $ (5,492) 326 10,106 (333)  
Celanese Corporation stockholders' equity 5,637 $ 0 $ (5,491) 372 11,274 (518)  
Balance as of the beginning of the period (in shares) at Dec. 31, 2022   108,473,932 61,661,493        
Balance as of the beginning of the period at Dec. 31, 2022 $ 6,105            
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock-based compensation, net of tax       (7)      
Purchases of treasury stock (in shares) 0   0        
Purchases of treasury stock, including related fees     $ 0        
Stock awards (in shares)   312,806          
Stock awards   $ 0          
Net earnings (loss) attributable to Celanese Corporation $ 91       91    
Common stock dividends         (76)    
Other comprehensive income (loss), net of tax 16         16  
Balance as of the beginning of the period, noncontrolling interest at Dec. 31, 2022 468           468
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net earnings (loss) attributable to noncontrolling interests 2           2
Dividends to noncontrolling interests             (1)
Distributions to noncontrolling interests             0
Balance as of the end of the period, noncontrolling interest at Mar. 31, 2023 469           $ 469
Balance as of the end of the period (in shares) at Mar. 31, 2023   108,786,738 61,661,493        
Balance as of the end of the period at Mar. 31, 2023 6,130            
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Celanese Corporation stockholders' equity $ 5,661 $ 0 $ (5,491) $ 365 $ 11,289 $ (502)